In 2016, #mycetoma was recognized among the #NTDs & thru partnerships and patient-centered research, @DNDi is working to make treatments safer, more effective, and accessible.
Continued research, innovation, and care are vital to end this disease.
#MycetomaAt10#BeatNTDs
Last week we participated at a high-level #WHA79 meeting reaffirming shared political commitment to strengthen cross-border collaboration and accelerate elimination of #malaria and neglected tropical diseases (#NTDs). Read @who's press release here: https://t.co/56fJWq27TR
#Mycetoma in Ethiopia’s Afar region is often detected late, leading to disability & limb loss. In this study, nearly 90% of patients presented after 12 months of symptoms and 13% required amputation. @PLOSNTDs
https://t.co/TSuF9rHR9h
Happening in 2 Days!
Join IMPAACT4HIV's upcoming cross-learning webinar exploring how Community-Led Monitoring (CLM) is helping communities identify barriers, strengthen clinic-community collaboration, and use data to drive meaningful change for Advanced HIV Disease (AHD) responses across Africa.
Featuring experiences and lessons from the DRC, Guinea (GRC), and Mozambique.
🔗Register here: https://t.co/FRuJ0psU8V
Finding new treatments for #Chagas disease is urgent. This study screened over 2,400 compounds and identified promising candidates, using approaches like cell painting to understand how they act against T. cruzi.
https://t.co/ceagkIPM9v
A powerful tribute from @ProfAHFahal, honors Dr @bornanyaoke (@DNDi ), the 2025 Mycetoma Ambassador. Her extraordinary leadership kept critical care alive for neglected patients during the darkest chapters of the Sudan conflict. 🧵👇
https://t.co/nGpps4CtpS
We welcome the new Global Action Plan on #AMR, incl. commitments to strengthen R&D & ensure equitable access to treatments. AMR should be integrated into global health reform discussions. #WHA79
Read full statement: https://t.co/rSstxXx3Ko
This #InternationalClinicalTrialsDay, the @MycetomaRC celebrates a global health milestone: leading the world’s first randomised clinical trial for #mycetoma, bringing hope to neglected communities! 🌟
Deep thanks to @DNDi, @Eisai, & others for their steadfast partnership!
We welcome Global Health Architecture reform discussions & stress biomedical innovation must be core. Market forces alone won’t deliver public‑health R&D. Reform must boost public‑interest models & ensure innovation is governed & financed for impact&equity https://t.co/rSstxXx3Ko
Coalitions matter – but how they’re built matters more. At the @ISNTD_Press arbovirus event, @IsabelaQRibeiro highlights how the #DengueAlliance, led by endemic countries, is collaborating to close treatment gaps for dengue, with equity and access built in from the start. #WHA79
Global preparedness requires strong partnerships.
At #WHA79, DG HERA and @pahowho are working together to turn collaboration into action — from #hantavirus and mosquito-borne diseases to surveillance, procurement and stronger epidemic intelligence capacities.
🦟 Mosquitoes and pathogens don't look at maps. They don't wait for visas, and they certainly don't recognize geopolitical borders.
#WHA79#Endmalaria#BeatNTDs#GlobalHealth
On this #ClinicalTrialsDay, we are celebrating a shift toward health equity.
By building local research networks & collaborating directly with patients & frontline workers, @DNDi is developing affordable, adapted life saving treatment.
#CTD2026#HealthEquity#GlobalHealth
On #InternationalClinicalTrialsDay, we celebrate the resilience of the @MycetomaRC, pioneers of the world’s first randomized #mycetoma clinical trial. Despite conflict and destruction @ProfAHFahal and his team continue to rebuild with extraordinary grit and determination. #NTDs
New tools are vital for #NTD control & elimination. We urge countries to finalise the NTD R&D blueprint, invest in inclusive research for women & children, and promote innovation for climate‑sensitive diseases. #WHA79
Full intervention: https://t.co/rSstxXx3Ko
We welcome continued efforts by Member States to advance the #PandemicAgreement & PABS annex. While negotiations continue, a PABS system – that delivers equitable innovation and access – is essential for preparedness. Read our intervention here: https://t.co/rSstxXx3Ko
#WHA79
This week, MMV and @DNDi drug discovery teams came together to exchange ideas, common challenges and lessons learned across our research.
From prioritizing promising compounds to advancing research in endemic countries, shared learning helps strengthen global health #innovation.
'This crisis is a tragic reminder that we will keep paying in lives if we do not invest in science before new viral threats emerge or reemerge.'
Read DNDi statement on the hantavirus outbreak and the need to invest in pandemic preparedness:
https://t.co/cQuWu01cpq